Zacks: Brokerages Anticipate Danaher Co. (DHR) Will Announce Earnings of $1.15 Per Share

Wall Street brokerages expect Danaher Co. (NYSE:DHR) to post earnings of $1.15 per share for the current fiscal quarter, Zacks reports. Six analysts have issued estimates for Danaher’s earnings. The highest EPS estimate is $1.16 and the lowest is $1.14. Danaher also reported earnings per share of $1.15 during the same quarter last year. The firm is scheduled to report its next earnings report on Thursday, July 18th.

On average, analysts expect that Danaher will report full-year earnings of $4.77 per share for the current fiscal year, with EPS estimates ranging from $4.74 to $4.80. For the next financial year, analysts forecast that the business will report earnings of $5.31 per share, with EPS estimates ranging from $4.94 to $5.77. Zacks’ EPS calculations are an average based on a survey of analysts that cover Danaher.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.01 by $0.06. Danaher had a return on equity of 11.61% and a net margin of 12.04%. The company had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.80 billion. During the same period in the previous year, the firm posted $0.99 earnings per share. The firm’s revenue for the quarter was up 3.9% on a year-over-year basis.

Several equities research analysts have weighed in on the company. Zacks Investment Research cut Danaher from a “hold” rating to a “sell” rating in a research note on Tuesday, April 30th. Janney Montgomery Scott boosted their target price on Danaher from $136.00 to $174.00 and gave the company a “buy” rating in a research report on Wednesday, April 17th. JPMorgan Chase & Co. restated an “overweight” rating and set a $140.00 target price on shares of Danaher in a research report on Monday, March 4th. Needham & Company LLC restated a “buy” rating and set a $138.00 target price (up previously from $114.00) on shares of Danaher in a research report on Thursday, February 28th. Finally, UBS Group boosted their target price on Danaher from $125.00 to $144.00 and gave the company a “buy” rating in a research report on Tuesday, February 26th. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Danaher presently has a consensus rating of “Buy” and a consensus target price of $131.75.

In related news, Director Walter G. Lohr sold 10,578 shares of the business’s stock in a transaction that occurred on Wednesday, February 27th. The stock was sold at an average price of $126.85, for a total value of $1,341,819.30. Following the completion of the sale, the director now owns 20,691 shares in the company, valued at $2,624,653.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Alan G. Spoon sold 1,913 shares of the business’s stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total value of $247,771.76. Following the completion of the sale, the director now owns 86,863 shares of the company’s stock, valued at approximately $11,250,495.76. The disclosure for this sale can be found here. Insiders sold 424,761 shares of company stock valued at $54,983,097 in the last quarter. 11.40% of the stock is owned by company insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in DHR. Laurel Wealth Advisors LLC bought a new position in Danaher in the fourth quarter worth approximately $27,000. CX Institutional increased its position in shares of Danaher by 188.7% in the 1st quarter. CX Institutional now owns 205 shares of the conglomerate’s stock valued at $27,000 after acquiring an additional 134 shares during the period. Hanson McClain Inc. increased its position in shares of Danaher by 852.9% in the 4th quarter. Hanson McClain Inc. now owns 324 shares of the conglomerate’s stock valued at $33,000 after acquiring an additional 290 shares during the period. Executive Wealth Management LLC acquired a new position in shares of Danaher in the 4th quarter valued at $39,000. Finally, Ruggie Capital Group purchased a new stake in Danaher in the fourth quarter valued at $40,000. Hedge funds and other institutional investors own 76.98% of the company’s stock.

NYSE DHR traded up $1.52 during trading hours on Thursday, hitting $132.27. 1,515,891 shares of the company were exchanged, compared to its average volume of 2,838,765. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.18 and a quick ratio of 1.74. Danaher has a 52 week low of $94.59 and a 52 week high of $134.67. The stock has a market capitalization of $92.68 billion, a P/E ratio of 29.26, a PEG ratio of 2.50 and a beta of 1.02.

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.51%. Danaher’s payout ratio is 15.04%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Further Reading: What is a Derivative?

Get a free copy of the Zacks research report on Danaher (DHR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.